Effect of invertebrate serine proteinase inhibitors on carrageenan-induced pleural exudation and bradykinin release

International Immunopharmacology

Volumn 4, Issue 10-11, 2004, Pages 1401-1408

  Malavazi Piza, Kelly C ^a   Araújo, Mariana S ^a   Godinho, Rosely O ^a   Tanaka, Aparecida S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bk; BmTIs; Boophilus microplus trypsin inhibitors pool; bradykinin; Bradykinin; EDTA; EIsynt; ethylenediaminetetraacetic acid; LDTI 2PL; Neutrophil elastase; Plasma kallikrein; Plasmin; Pleurisy; synthetic neutrophil elastase inhibitor

Indexed keywords

APROTININ; BRADYKININ; CARRAGEENAN; LEUKOCYTE ELASTASE INHIBITOR; PLASMA KALLIKREIN; PLASMIN INHIBITOR; TRYPTASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SUBSTRATE; INFLAMMATORY INFILTRATE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; NONHUMAN; PLEURA CAVITY; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; RAT; SPECIES COMPARISON;

ANIMALS; BRADYKININ; CARRAGEENAN; CHEMOTAXIS, LEUKOCYTE; EXUDATES AND TRANSUDATES; IXODIDAE; LEECHES; MALE; PLASMIN; PLEURISY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SERINE PROTEINASE INHIBITORS;

EID: 4143080454     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.06.004     Document Type: Article

References (46)

1. Vinegar R., Truax J.F., Selph J.L. Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc. Soc. Exp. Biol. Med. 143:1973;711-714
2. Murai N., Nagai K., Fujisawa H., Hatanaka K., Kawamura M., Harada Y. Concurrent evolution and resolution in an acute inflammatory model of rat carrageenin-induced pleurisy. J. Leukoc. Biol. 73(4):2003;456-463
3. Yager D.R., Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen. 7(6):1999;433-441
4. Cepinskas G., Sandig M., Kvietys P.R. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. J. Cell Sci. 112(Pt 12):1999;1937-1945
5. Hermant B., Bibert S., Concord E., Dublet B., Weidenhaupt M., Vernet T., et al. Identification of proteinases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J. Biol. Chem. 278(16):2003;14002-14012
6. Bank U., Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69(2):2001;197-206
7. Kannan-Thulasiraman P., Shapiro D.J. Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9. J. Biol. Chem. 277(43):2002;41230-41239
8. Brower M.S., Harpel P.C. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 257(16):1982;9849-9854
9. Wallace E.M., Perkins S.J., Sim R.B., Willis A.C., Feighery C., Jackson J. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes. Mol. Med. 3(6):1997;385-396
10. Widström O., Egberg N., Chmielewska J., Blomback M. Fibrinolytic and coagulation mechanisms in stages of inflammation: a study of BCG-induced pleural exudate in guinea pig. Thromb. Res. 29(5):1983;511-519
11. Widstrom O., Chmielewska J., Blomback M. Measurements of enzymatic activities in pleural exudates with chromogenic substrates. Thromb. Res. 42(6):1986;859-864
12. Esmon C.T. Inflammation and thrombosis. Thromb. Haemost. 1(7):2003;1343-1348
13. Moir E., Robbie L.A., Bennett B., Booth N.A. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis. Thromb. Haemost. 87(6):2002;1006-1010
14. Moir E., Booth N.A., Bennett B., Robbie L.A. Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism. Br. J. Haematol. 113(1):2001;72-80
15. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44(1):1992;1-80
16. Saleh T.S., Calixto J.B., Medeiros Y.S. Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy. Eur. J. Pharmacol. 331(1):1997;43-52
17. Böckman S., Paegelow I. Kinins and kinins receptors: importance for the activation of leukocytes. J. Leukoc. Biol. 68(5):2000;587-592
18. Figueroa C.D., Stuardo M., Gonzalez C.B., Nualart F., Corthorn J., Bhoola K.D., et al. Hydrolysis of kininogens by degranulated human neutrophils and analysis of bradykinin as chemotactic factor for cells isolated from peripheral blood. Immunopharmacology. 43(2-3):1999;211-217
19. Rojkjaer R., Schmaier A.H. Activation of the plasma kallikrein/kinin system on endothelial cell membranes. Immunopharmacology. 43(2-3):1999;109-114
20. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110
21. Campos I.T.N., Silva M.N., Azzolini S.S., Souza A.F., Sampaio C.A.M., Fritz H., et al. Evaluation of phage display system and LDTI (leech derived tryptase inhibitor) as a tool for understanding the serine proteinase specificities. Arch. Biochem. Biophys. 425(1):2004;87-94
22. 52]aprotinin. Biol. Chem. Hoppe-Seyler. 369:1998;27-35
23. Tanaka A.S., Andreotti R., Gomes A., Torquato R.J., Sampaio M.U., Sampaio C.A. A double headed serine proteinase inhibitor-human plasma kallikrein and elastase inhibitor - from Boophilus microplus larvae. Immunopharmacology. 45(1-3):1999;171-177
24. Shimamoto K., Ando T., Nako T., Tanaka S., Sakuma M., Miyahara M. A sensitive radioimmunoassay methods for urinary kinins in man. J. Lab. Clin. Med. 91(5):1978;721-728
25. Shimamoto K., Ando T., Tanaka S., Imura O. The determination of kinin and glandular kallikrein in human biological fluids. Atemwegs - Lungenkr. Jahrgang. 14(1):1988;S29-S36
26. Gozzo A.J., Nunes V.A., Carmona A.K., Nader H.B., von Dietrich C.P., Silveira V.L., et al. Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int. J. Immunopharmacol. 2(13-14):2002;1861-1865
27. Katori M., Ikeda K., Harada Y., Uchida Y., Tanaka K., Oh-Ishi S. A possible role of prostaglandins and bradykinin as a trigger of exudation in carrageenin-induced rat pleurisy. Agents Actions. 8(1-2):1978;108-112
28. Oh-Ishi S., Hayashi I., Hayashi M., Yamaki K., Yamasu A., Nakano T., et al. Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats. Agents Actions. 18(3-4):1986;450-454
29. Docherty A.J., Crabbe T., O'Connell J.P., Groom C.R. Proteases as drug targets. Biochem. Soc. Symp. 70:2003;147-161
30. Hiemstra P.S. Novel roles of protease inhibitors in infection and inflammation. Biochem. Soc. Trans. 30(2):2002;116-120
31. Aldonyte R., Jansson L., Janciauskiene S. Concentration-dependent effects of native and polymerised alpha1-antitrypsin on primary human monocytes, in vitro. BMC Cell Biol. 5(1):2004;1-11
32. Gourine A.V., Gourine V.N., Tesfaigzi Y., Caluwaerts N., Van Leuven F., Kluger M.J. Role of alpha(2)-macroglobulin in fever and cytokine responses induced by lipopolysaccharide in mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 283(1):2002;R218-R226
33. Morgan K., Marsters P., Morley S., van Gent D., Hejazi A., Backx M., et al. Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3′ enhancer. Biochem. J. 365(Pt 2):2002;555-560
34. Uchida Y., Tanaka K., Harada Y., Ueno A., Katori M. Activation of plasma kallikrein-kinin system and its significant role in pleural fluid accumulation of rat carrageenin-induced pleurisy. Inflammation. 7(2):1983;121-131
35. Majima M., Sunahara N., Harada Y., Katori M. Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. Biochem. Pharmacol. 45(3):1993;559-567
36. Majima M., Nishiyama K., Iguchi Y., Yao K., Ogino M., Ohno T., et al. Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation. Inflamm. Res. 45(8):1996;416-423
37. Barlas A., Sugio K., Greenbaum L.M. Release of T-kinin and bradykinin in carrageenan induced inflammation in the rat. FEBS Lett. 190(2):1985;268-270
38. Tissot M., Regoli D., Giroud J.P. Bradykinin levels in inflammatory exudates. Inflammation. 9(4):1985;419-424
39. Majima M., Kawashima N., Hiroshi I., Katori M. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 121(4):1997;723-730
40. Hayashi I., Amano H., Ishihara K., Kumagai Y., Yoshimura H., Majima M.C. The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy. Life Sci. 70(8):2002;937-949
41. Ossovskaya V.S., Bunnett N.W. Protease-activated receptors; contribution to physiology and diseases. Physiol. Rev. 84:2003;579-621
42. Janciauskiene S., Zelvyte I., Jansson L., Stevens T. Divergent effects of alpha1-antitrypsin on neutrophil activation, in vitro. Biochem. Biophys. Res. Commun. 315(2):2004;288-296
43. Moraga F., Lindgren S., Janciaskiene S. Effects of noninhibitory alpha-1-antitrypsin on primary human monocyte activation in vitro. Arch. Biochem. Biophys. 386(2):2001;221-226
44. Moraga F., Janciauskiene S. Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J. Biol. Chem. 275(11):2000;7693-7700
45. Stockley R.A., Shaw J., Afford S.C., Morrison H.M., Burnett D. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am. J. Respir. Cell Mol. Biol. 2(2):1990;163-170
46. Zelvyte I., Lindgren S., Janciauskiene S. Multiple effects of alpha1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness. Eur. J. Cancer Prev. 12(2):2003;117-124